Clin2
NCT07424183Possibly a fitNot yet recruiting

Combination thyroid hormone therapy for ongoing hypothyroid symptoms

Hypothyroidism Primary

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests a new way of providing thyroid hormone therapy for people who still feel tired and other bothersome symptoms despite currently taking a standard thyroid pill (levothyroxine). It combines two types of thyroid hormone (T4 and T3) to see if it better relieves symptoms than the usual treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are 18 to 70 years old.
  • You have had hypothyroidism (underactive thyroid) for at least 6 months due to either your thyroid not working or having it surgically removed.
  • You take levothyroxine (thyroid hormone pill) daily, 75 to 150 mcg, and have been on the same dose for at least 3 months.
  • Your thyroid blood test (TSH) is within a normal range (0.5 to 4.0 mU/L).
  • You still have bothersome hypothyroid symptoms for more than 2 months, such as fatigue, weight gain, or feeling sluggish.
  • If you are able to have children, you must use effective birth control during the study and for 4 weeks after.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06073665Recruiting· Phase 4
Thyroid hormone dosing in older adults

This study tests whether current thyroid medication doses are appropriate for people aged 65 and older. The goal is to find the best dose for each person to improve well-being.

Philadelphia, Pennsylvania
NCT00001159Recruiting
Thyroid disorder natural history study

This study observes people with various thyroid conditions, including overactive or underactive thyroid, to learn more about how these disorders develop and progress over time. It may help improve future diagnosis and treatment.

Bethesda, Maryland
NCT05682482Recruiting· Phase 3
Combination T4/T3 vs T4 alone for autoimmune hypothyroid fatigue

This trial compares adding T3 (plus T4) versus taking only T4 to see if it improves severe ongoing tiredness in people with autoimmune hypothyroidism. You would stay on your thyroid medicine plan during the study and be monitored with blood tests and health checks.

Almere Stad
NCT06731764Recruiting· Phase 2/Phase 3
New ways to treat hypothyroidism

This study tests a new approach for people with hypothyroidism who are already taking levothyroxine. You may be able to join if you are on a certain dose and do not have other health conditions that could affect the results.

Farmington, Connecticut
NCT06647602Not yet recruiting
Thyroid hormone after radioactive iodine treatment

This study compares two ways of replacing thyroid hormone after radioactive iodine therapy for high-risk thyroid cancer. It aims to find which approach is more effective and better for patients.

Groningen, Provincie Groningen
NCT07239674Not yet recruiting· Phase 3
Combined thyroid medications for TSH control in thyroid cancer

This trial tests whether combining two thyroid hormone medications (levothyroxine and desiccated thyroid extract) can better keep your TSH in the target range after thyroid cancer surgery. The goal is to reduce the chance of the cancer coming back while managing side effects.

Hear when a new Hypothyroidism Primary trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.